Leukemia Research
Antibody-Drug Conjugate [ADC] Treatment of Leukemia
Publication date: Available online 20 April 2023Source: Leukemia ResearchAuthor(s): Hassan Tawhid Hassan
Leukemia Research
Corrigendum to “Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapy” [Leuk. Res. 122 (2022) 106949]
Publication date: Available online 16 April 2023Source: Leukemia ResearchAuthor(s): Yanhua Yue, Yang Cao, Fei Wang, Naidong Zhang, Ziwei Qi, Xunyuan Mao, Shuxin Guo, Feng Li, Yanting Guo, Yan Lin, Weimin Dong, Yuhui Huang, Weiying Gu
Leukemia Research
Efficacy and Tolerability of Isocitrate Dehydrogenase Inhibitors in Patients with Acute Myeloid Leukemia: A Systematic Review of Clinical Trials
Publication date: Available online 14 April 2023Source: Leukemia ResearchAuthor(s): Wajeeha Aiman, Muhammad Ashar Ali, Muhammad Abdul Basit, Zainab Omar, Muhammad Suleman, Muhammad Hassan, Taimoor Jamil, Muhammad Saad Anwar, Zubair Shafique, Gurneel Dh…
Leukemia Research
Clonal Hematopoiesis: Origins and Determinants of Evolution
Publication date: Available online 14 April 2023Source: Leukemia ResearchAuthor(s): Lourdes M. Mendez, Mrinal M. Patnaik
Leukemia Research
A Phase I Study of the Combination of Palbociclib and Dexamethasone for the Treatment of Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Publication date: Available online 6 April 2023Source: Leukemia ResearchAuthor(s): Lindsay Wilde, Patrizia Porazzi, Rossana Trotta, Marco De Dominici, Neil Palmisiano, Gina Keiffer, Kaitlin Rancani, Kathryn Yingling, Bruno Calabretta, Margaret Kasner
Leukemia Research
Corrigendum to “Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update” [Leukemia Research 125 (2023) 107016]
Publication date: Available online 3 April 2023Source: Leukemia ResearchAuthor(s): Carolyn Owen, Versha Banerji, Nathalie Johnson, Alina Gerrie, Andrew Aw, Christine Chen, Sue Robinson
Leukemia Research
Analysis of patient-reported experiences up to 2 years after receiving idecabtagene vicleucel (ide-cel, bb2121) for relapsed or refractory multiple myeloma: longitudinal findings from the phase 2 KarMMa trial
Publication date: Available online 3 April 2023Source: Leukemia ResearchAuthor(s): Michel Delforge, Paula Rodríguez Otero, Nina Shah, Olga Moshkovich, Julia Braverman, Devender S. Dhanda, Sally Lanar, Jennifer Devlen, Matthew Miera, Heather Gerould, Ti…
Leukemia Research
Discrepancy in Transcriptomic Profiling Between CD34+ Stem Cells and Primary Bone Marrow Cells in Myelodysplastic Neoplasm
Publication date: Available online 29 March 2023Source: Leukemia ResearchAuthor(s): Howard Lopes Ribeiro Junior, Paola Gyuliane Gonçalves, Daniel Antunes Moreno, João Vitor Caetano Goes, Roberta Taiane Germano de Oliveira, Carlos Victor Montefusco-Pere…
Leukemia Research
Response to chemotherapy in juvenile myelomonocytic leukemia and its clinical implications for survival: A retrospective registry-based study of the Korean Pediatric Hematology-Oncology Group
Publication date: Available online 28 March 2023Source: Leukemia ResearchAuthor(s): Eun Sang Yi, Hee Jo Baek, Hee Young Ju, Seong Koo Kim, Jae Wook Lee, Bin Cho, Bo Kyung Kim, Hyoung Jin Kang, Hoon Kook, Eu Jeen Yang, Young Tak Lim, Won Kee Ahn, Seung …
Leukemia Research
Rituximab induced cytokine release with high serum IP-10 (CXCL10) concentrations is associated with infusion reactions
Publication date: Available online 29 March 2023Source: Leukemia ResearchAuthor(s): Jeremiah E. Moore, Paige C. Bloom, Charles C. Chu, Jennifer E. Bruno, Christine A. Herne, Andrea M. Baran, Sally A. Quataert, Timothy R. Mosmann, Ronald P. Taylor, Dani…